Drug Shortage Report for ATHENA-ONDANSETRON ODT

Last updated on 2022-05-19 History
Report ID 68659
Drug Identification Number 02444674
Brand name SANDOZ ONDANSETRON ODT
Common or Proper name ONDANSETRON ODT
Company Name ATHENA PHARMACEUTIQUES SAS
Market Status MARKETED
Active Ingredient(s) ONDANSETRON
Strength(s) 4MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size 10
ATC code A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-02-25
Actual start date 2019-03-08
Estimated end date 2019-06-03
Actual end date 2019-06-03
Shortage status Resolved
Updated date 2022-05-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address ESPACE ARNOLD DE VILLE, 12 RUE GEORGES BLANDON
LOUVECIENNES, --
FRANCE 78430
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2022-05-19 French Compare
v8 2022-05-19 English Compare
v7 2019-04-17 French Compare
v6 2019-04-17 English Compare
v5 2019-02-26 English Compare
v4 2019-02-18 French Compare
v3 2019-02-18 English Compare
v2 2018-12-05 French Compare
v1 2018-12-05 English Compare

Showing 1 to 9 of 9